Reference List: “No Action Today, No Cure Tomorrow”

PowerPoint Presentation for Antibiotic Awareness Week 2014

  1. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States in the 20th century. Journal of the American Medical Association 1999;281(1):61-66. (Available online in full text at
  1. Saxon, W. (1999) “Anne Miller, 90, First Patient Who Was Saved by Penicillin”. New York Time, June 9. Available from last accessed 12 November 2013.
  2. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher H, Scheld WM, Bartlett JG, and Edwards J. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clinical Infectious Diseases 2008; 46:155- 164.
  3. Fleming A. Penicillin Nobel Lecture, December 11, 1945
  1. Pray LA. Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive, Insight Pharma Reports 2008, in Looke D. The Real Threat of Antibiotic Resistance[online presentation]. (accessed 30 Oct 12)
  2. Centers for Disease Control and Prevention. Access at
  1. Infectious Diseases Society of America. Patient stories. Accessed 15 October 2014 at
  2. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical Infectious Diseases 2009; 49:1175–1184.
  3. World Health Organisation. Antimicrobial resistance: global report on surveillance 2014. Access at
  1. Mendes RE, Mendoza M, Banga Singh KK, Castanheira M, Bell JM, Turnidge JD, Lin SSF, Jones RN. “Regional Resistance Surveillance Program Results for Twelve Asia-Pacific Nations (2011)”. Antimicrobial Agents and Chemotherapy. Published ahead of print 19 August 2013, doi:10.1128/AAC.01121-13.
  1. Xiao YH, Giske CG, Wei ZQ, Shen P, Heddini A, Li LJ. “Epidemiology and characteristics of antimicrobial resistance in China.” Drug Resistance Updates: Reviews and Commentaries In Antimicrobial And Anticancer Chemotherapy. 2011 Aug-Oct; Vol. 14(4-5), pp. 236-50. Date of Electronic Publication: 2011 Jul 31.
  1. Chong Y, Yakushiji H, Ito Y, Kamimura T. “Clinical and molecular epidemiology of extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan”. European Journal of Clinical Microbiology and Infectious Diseases, January 2011, Volume 30, Issue 1, pp 83-87.
  1. Turnidge, J, Kotsanas, D, Munckhof, W, Roberts, S, Bennett, C. Staphylococcus aureusbacteraemia: a major cause of mortality in Australia and New ZealandMedical Journal of Australia 2009; 191 (7): 368-373.
  2. Looke, DL, Gottleib, T, Jones, CA and Paterson, DL (2013) Gram-negative resistance: can we combat the coming of a new “Red Plague”? Medical Journal of Australia. 198 (5): 243-4
  3. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M, and the European Antimicrobial Resistance Surveillance System and European Surveillance of Antimicrobial Consumption Project Groups. Antimicrobial drug use and resistance in Europe. Emerging Infectious Diseases 2008; 14(11):1722-1730
  4. South Australian Infection Control Service. National Antimicrobial Utilisation Surveillance Program (NAUSP) 2013-14 Annual Report.
  5. Adapted from Spellberg B et al. The epidemic of antibiotic resistant infections: A call to action for the medical community from the Infectious Diseases Society of America. Clin Inf Dis 2008;48:155-64
  6. Spellberg B. New antibiotic development: barriers and opportunities in 2012. APUA Clinical Newsletter 2012; 30(1):8-10
  7. Duguid M, Cruickshank M (editors). Antimicrobial Stewardship in Australian Hospitals. Sydney: Australian Commission on Safety and Quality in Health Care, 2011.
  8. Australian Commission on Safety and Quality in Health Care. National Safety and Quality Health Service Standards. Sydney. ACSQHC 2011.
  9. Nathwani D and Sneddon J. Practical Guide to Antimicrobial Stewardship. Access at
  10. Antibiotic Expert Group, editor. Therapeutic Guidelines – Antibiotic.Version 14.Melbourne. Therapeutic Guidelines Ltd 2010
  11. Dr Margaret Chan, Keynote address at the conference on Combating antimicrobial resistance: time for action. Copenhagen, Denmark 14 March 2012. Accessed 22/9/14 at

1

REFERENCES: No action today, no cure tomorrow. 2014 Antibiotic Awareness Week Presentation

Available at